Goodwin Procter, a leading Am Law 50 and Global 50 law firm, announced today that 19 attorneys have been elected to the firm’s partnership, effective Oct. 1.
“We are delighted to welcome our new partners, all of whom exemplify legal excellence. These lawyers have outstanding leadership skills, a deep knowledge of their industries and strong client relationships,” said David Hashmall, chairman of Goodwin Procter. “We look forward to the many contributions this next generation of talent will bring to Goodwin and our clients.”
The newly elected partners are:
- Jason C. Breen (Technology & Life Sciences; Los Angeles) represents start-up and later stage companies in the software, technology and life sciences industries throughout their corporate life cycle, with a particular focus on mergers, acquisitions, divestitures, financings and other strategic transactions.
- Cameron L. Contizano (Private Equity; Washington, D.C.) focuses on corporate and commercial transactions and represents investors, issuers and portfolio companies in mergers, acquisitions, divestitures, leveraged buyouts, growth equity investments, venture capital financing, secondary transactions, private company liquidity programs, reorganizations, recapitalizations and joint ventures, and other corporate matters.
- Michael B. Cottler (IP Litigation; New York) concentrates on patent issues in the areas of pharmaceuticals and biotechnology, and represents pharmaceutical companies in complex litigations, particularly Hatch-Waxman/ANDA cases, involving chemical agents and products across a spectrum of medical indications.
- Robert M. Crawford, Jr. (Technology & Life Sciences; Boston) represents technology, pharmaceutical and other life science companies in connection with their commercial, M&A and intellectual property transactions, including complex strategic collaboration, co-development, licensing and partnering transactions, and is a leader in the firm’s generic pharmaceutical transactions practice.
- Christopher Dwyer (Private Equity; New York) advises clients on a wide range of matters, including mergers, asset and stock acquisitions and divestitures, leveraged recapitalizations, financings, executive compensation, and other corporate matters.
- Robert Frederickson, III (IP Litigation; Boston) concentrates on intellectual property and patent litigation and represents clients in matters involving computer software and hardware, smartphone applications, voice over IP telephony, cellular networks, electronic medical records, Ethernet routing and Power-over-Ethernet switches, and pharmaceuticals.
- Andrew T. Hill (Technology & Life Sciences; Silicon Valley) represents technology companies through their entire corporate life-cycle, including on matters involving pre-incorporation planning, general corporate representation and counseling, venture capital financings, public offerings, corporate governance and public company representation, and mergers and acquisitions.
- Daniel S. Karelitz (Tax; Boston) focuses on private equity, growth equity and venture capital investment structuring; real estate and infrastructure fund formation and investment structuring; and REIT capital market transactions.
- Jacqueline Mercier (Technology & Life Sciences; Boston) concentrates on mergers, acquisitions, tender and exchange offers and other strategic transactions, and also advises public companies on corporate governance, securities offerings, securities law compliance, proxy contests and general corporate matters.
- Katherine L. Murphy (Real Estate Capital Markets; Boston) represents landlords, tenants, lenders, investors and developers in all aspects of commercial lease transactions throughout the United States, including large and small scale leases for office, retail, industrial, laboratory, medical office, biotech and data center space.
- William Burnet Pearce (Private Equity; San Francisco) represents private equity sponsors and public and private companies in structuring and negotiating secured and unsecured domestic and cross-border debt financing transactions, including senior, mezzanine and subordinated debt facilities, acquisition-financing transactions, working capital facilities and loan workouts and restructurings.
- Anne E. Railton (Securities Litigation & White Collar Defense; New York) represents corporations and individuals in complex criminal and civil government investigations and prosecutions, internal corporate investigations and business and securities litigation.
- Srikanth K. Reddy (IP Litigation; Boston) counsels clients on patent, trademark, copyright and trade secret matters and his patent litigation work includes enforcement investigations before the U.S. International Trade Commission, Hatch-Waxman/ ANDA cases, other district court patent litigation matters and post-grant proceedings before the Patent Trial and Appeal Board.
- Sarah A. Solomon (Technology & Life Sciences; San Francisco) represents biotechnology, pharmaceutical, medical device, diagnostic and other life sciences companies in connection with their intellectual property, commercial and M&A transactions, and regularly advises on complex strategic collaboration, partnering and licensing transactions and product-based mergers and acquisitions.
- James O. Spence (Real Estate Capital Markets; London) advises clients on domestic and cross-border real estate investments and private M&A transactions, and represents a variety of stakeholders across the real estate sector on all aspects of investments in European real estate, including structured sales and acquisitions, joint ventures, real estate funds, club deals and investment management mandates.
- Meghan K. Spillane (Securities Litigation & White Collar Defense; New York) represents corporations and individuals in federal criminal and civil investigations, securities class actions and derivative suits, SEC actions, and complex civil litigation matters.
- Liam F. Timoney (Private Equity; New York) represents private equity sponsors and their portfolio companies in a wide range of corporate transactions, including leveraged acquisitions, growth equity investments and cross-border transactions.
- Chris Wilson (Private Equity; Boston) focuses on advising private equity sponsors and their portfolio companies in mergers and acquisitions, growth equity and venture capital investments, and general corporate matters, and counsels financial institutions and asset managers on transactional matters.
Goodwin Procter LLP is a leading Am Law 50 and Global 50 law firm, with offices across the United States and in Europe and Asia. Excelling at complex transactional work and high-stakes litigation, the firm combines in-depth legal knowledge with practical business experience to help clients maximize opportunities and manage risk. With more than 850 lawyers, Goodwin offers innovative counsel and delivers results through a client-centric and collaborative approach. The firm focuses on matters involving financial institutions, intellectual property, private equity, real estate capital markets, securities litigation/white collar defense, and technology/life sciences. Information may be found at www.goodwinprocter.com. Follow us on Twitter @goodwinprocter.